Liver Diseases D008107

Diseases [C] » Digestive System Diseases [C06] » Liver Diseases

Description

Pathological processes of the LIVER.   MeSH

Hierarchy View

Subtype Terms (24)

alpha 1-Antitrypsin Deficiency
24 drugs (13 approved, 11 experimental)

Budd-Chiari Syndrome
 

Chemical and Drug Induced Liver Injury
32 drugs (24 approved, 8 experimental)

Cholestasis, Intrahepatic
5 drugs (4 approved, 1 experimental)

Fatty Liver
82 drugs (38 approved, 44 experimental)

Focal Nodular Hyperplasia
1 experimental drug

Hepatic Infarction
 

Hepatic Insufficiency
56 drugs (34 approved, 22 experimental)

Hepatic Veno-Occlusive Disease
3 approved drugs

Hepatitis
39 drugs (25 approved, 14 experimental)

Hepatolenticular Degeneration
21 drugs (11 approved, 10 experimental)

Hepatomegaly
5 approved drugs

Hepatopulmonary Syndrome
6 approved drugs

Hepatorenal Syndrome
10 drugs (8 approved, 2 experimental)

Hypertension, Portal
66 drugs (40 approved, 26 experimental)

Liver Abscess
5 approved drugs

Liver Cirrhosis
273 drugs (157 approved, 116 experimental)

Liver Diseases, Alcoholic
25 drugs (10 approved, 15 experimental)

Liver Diseases, Parasitic
 

Liver Neoplasms
361 drugs (151 approved, 210 experimental)

Peliosis Hepatis
 

Porphyrias, Hepatic
 

Tuberculosis, Hepatic
 

Zellweger Syndrome
7 drugs (6 approved, 1 experimental)


Phase 1 Indicated Drugs (215)


Organization Involved with Phase 4 Indications (152)

Organization Involved with Phase 3 Indications (75)

Organization Involved with Phase 2 Indications (167)

Organization Involved with Phase 1 Indications (120)

Organization Involved with Other Experimental Indications (66)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.